Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2022-11-20 | 2022-12-02 | 175309 |
| APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2017-09-26 | 2017-11-07 | 23536 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2018-10-02 | 2018-10-12 | 62864 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2017-06-26 | 2017-07-17 | 13970 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Actual shortage | 2025-10-16 | 2025-10-16 | 269748 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2019-09-25 | 2019-10-22 | 94731 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2021-06-25 | 2021-10-05 | 141526 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2017-07-26 | 2017-11-07 | 17202 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2017-07-26 | 2017-10-24 | 17205 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2023-05-26 | 2023-07-13 | 193203 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2018-05-22 | 2018-09-09 | 49970 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Actual shortage | 2025-09-04 | 2025-09-04 | 266652 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2017-12-19 | 2018-07-04 | 33780 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2020-06-10 | 2020-06-15 | 117339 |
| APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2021-01-18 | 2021-03-15 | 131812 |
| APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2019-08-07 | 2019-09-23 | 91067 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2017-03-10 | 2017-07-20 | 61 |
| APO-ATOMOXETINE | 100MG | CAPSULE | Resolved | 2024-05-24 | 2024-10-11 | 228792 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2025-06-19 | 2025-06-27 | 260675 |
| APO-ATOMOXETINE | 60MG | CAPSULE | Resolved | 2017-03-10 | 2017-07-20 | 64 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |